Huma obtains multi-condition Saudi FDA Class C regulatory certification for its configurable SaMD disease management platform

Huma obtains multi-condition Saudi FDA Class C regulatory certification for its configurable SaMD disease management platform. Huma Bahrain Iran Iraq Jordan Kuwait Lebanon Oman Palestine Qatar Saudi Arabia Syria United Arab Emirates Yemen United States of America United Kingdom Middle East

Huma's platform is ready to use, reducing the time and cost for other companies to bring regulated SaMD products to market, democratising digital health innovation across the industryClass C certification expands the patient population and level of disease severity that can be managed; allowing delivery of personalised care through the use of predictive algorithmsClinical evidence from over 20 peer-reviewed publications and studies were submitted for regulatory assessment of clinical safety and efficacyand follow us on LinkedIn at Huma

Logo - https://mma.prnewswire.com/media/1427908/Huma_Logo.jpg    

View original content:https://www.prnewswire.co.uk/news-releases/huma-obtains-multi-condition-saudi-fda-class-c-regulatory-certification-for-its-configurable-samd-disease-management-platform-301995203.html